Regen Biopharma Seeks Orphan Drug Designation for Lead Product
Regen Biopharma’s pursuit of an orphan drug designation for Hemaxellerate, its stem cell-derived therapy for aplastic anemia, marks a...
Respiree Closes $11.6M Series A Financing Round
Respiree Secures $11.6M Series A to Expand AI-Powered Patient Monitoring Platform Respiree, a health tech company focused on AI-driven...
Roche’s Strong Momentum: 7% Growth in H1 2025
Roche Reports Robust H1 2025 Performance Driven by Pharmaceutical Growth Roche has announced strong financial results for the first...
Pfizer, BioNTech Get CHMP Nod for Adapted COVID-19 Vaccine in EU
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Pfizer...
Sarclisa Approved in EU for Newly Diagnosed Multiple Myeloma
Sanofi secures expanded EU approval for Sarclisa in newly diagnosed multiple myeloma, bolstering its presence in the competitive myeloma...
Rakovina Therapeutics Enhances Warrant Program
Rakovina Therapeutics is incentivizing early warrant exercises in a move to bolster its cash position and potentially streamline its...
Cabometyx® Approved in EU for Advanced Neuroendocrine Tumors
Cabometyx Secures Broad EU Approval for Neuroendocrine Tumors, Reshaping the Treatment Landscape Ipsen’s cabozantinib (Cabometyx) has received European Commission...
Alterity Therapeutics Publishes Novel MRI Endpoint Data
Alterity Therapeutics’ recently published research in the •Annals of Clinical and Translational Neurology• highlights a significant advancement in Multiple...
tcg labs soleil secures $400m, expands global R&D
TCG Labs Soleil secures an additional $400 million in funding, doubling down on its unique venture-biotech hybrid model. This...
MediPharm Labs Launches New CBN Oil Nighttime Inhaler
Medipharm Labs has launched a new CBN/THC nighttime inhaler in Canada, expanding its cannabinoid product portfolio beyond its existing...